Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Discriminated Against Female Sales Reps
Pharmalot
Monday, May 17, 2010 - 4:28pm
tags:
Novartis, lawsuits, discrimination
How Pharmaceutical Companies Profit From OTC Products
Minyanville
Monday, May 17, 2010 - 4:26pm
tags:
OTC, JNJ, Pfizer, GSK, Proctor & Gamble
Wider Loss at Medivation
Yahoo/Zacks.com
Monday, May 17, 2010 - 4:24pm
tags:
Medivation, earnings, Elan, AstraZeneca, JNJ
Exelixis Pharma Narrows Loss
Yahoo/Zacks.com
Monday, May 17, 2010 - 1:35pm
tags:
Exelixis, earnings, Bristol-Myers Squibb, Sanofi
Revenues Dip at Alkermes
Yahoo/Zacks.com
Monday, May 17, 2010 - 1:34pm
tags:
Alkermes, earnings, Cephalon, JNJ
Pharma Continues Headlong Rush Into Branded Generics
Seeking Alpha
Monday, May 17, 2010 - 10:44am
tags:
generics, Pfizer, Abbott Laboratories, GSK
Simcere Wants to Sell OTC Division, Add Prescription Drug Partnerships
Seeking Alpha
Monday, May 17, 2010 - 10:43am
tags:
Simcere, OTC, M&A, generics, China
Teva says Lou Gehrig's disease drug fails in study
Yahoo/AP
Monday, May 17, 2010 - 10:42am
tags:
Teva Pharmaceuticals, clinical trials, Lou Gehrig's disease, Talampanel
What Investors Think About BioSante Pharmaceuticals
Motley Fool
Monday, May 17, 2010 - 10:40am
tags:
BioSante, investors
Cell Therapeutics: 45 Days Until Bankruptcy?
Minyanville
Monday, May 17, 2010 - 10:39am
tags:
Cell Therapeutics, bankruptcy
Congress asks J&J chief to testify about recall
Fierce Pharma
Monday, May 17, 2010 - 10:37am
tags:
recalls, congress, JNJ, Pharma CEOs, William Weldon
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Street Insider
Monday, May 17, 2010 - 10:36am
tags:
Amgen, BLA, FDA, denosumab, RANK Ligand inhibitor
Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010
Yahoo
Monday, May 17, 2010 - 10:35am
tags:
Eli Lilly, cancer, oncology, ASCO, pipelines
Bulls Expect This Drug Maker to Rally
CNBC
Monday, May 17, 2010 - 10:34am
tags:
Celgene
Merck's Busy Road Ahead
Seeking Alpha
Monday, May 17, 2010 - 10:33am
tags:
Merck, biosimilars
Glaxo's Radical Heart Drug
Forbes
Monday, May 17, 2010 - 10:32am
tags:
GSK, darapladib
Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Seeking Alpha
Monday, May 17, 2010 - 9:57am
tags:
follow-on biologics, Aranesp, Merck, Amgen, Teva Pharmaceuticals, anemia
Astellas Raises Offer for OSI Pharma to $4 Billion
Bloomberg
Monday, May 17, 2010 - 9:41am
tags:
Astellas, OSI Pharmaceuticals, M&A
Glaxo Plays Catch-Up in Emerging Markets ‘Land Grab’
Bloomberg
Monday, May 17, 2010 - 9:38am
tags:
GSK, emerging markets, India, China
China Biotech Week in Review: M&A, Partnerships and Earnings
Seeking Alpha
Sunday, May 16, 2010 - 4:29pm
tags:
China, M&A, Genzyme, JNJ, Eli Lilly, Roche, Mindray, WuXi PharmaTech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.